Home/Filings/4/0001181431-14-014031
4//SEC Filing

INVIVO THERAPEUTICS HOLDINGS CORP. 4

Accession 0001181431-14-014031

CIK 0001292519operating

Filed

Mar 25, 8:00 PM ET

Accepted

Mar 26, 6:46 PM ET

Size

8.2 KB

Accession

0001181431-14-014031

Insider Transaction Report

Form 4
Period: 2014-03-24
REYNOLDS FRANCIS
DirectorCEO, CFO10% Owner
Transactions
  • Sale

    Common Stock

    2014-03-24$1.85/sh22,900$42,3659,448,920 total
  • Sale

    Common Stock

    2014-03-25$1.78/sh12,500$22,2509,436,420 total
  • Sale

    Common Stock

    2014-03-26$1.71/sh12,500$21,3759,423,920 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    23,488
Footnotes (3)
  • [F1]All sales between $1.65 - $1.95.
  • [F2]All sales between $1.72 - $1.90.
  • [F3]All sales between $1.67 - $1.77.

Issuer

INVIVO THERAPEUTICS HOLDINGS CORP.

CIK 0001292519

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001292519

Filing Metadata

Form type
4
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 6:46 PM ET
Size
8.2 KB